Clinical blood biochemical indicator analysis is a cornerstone of modern laboratory medicine, quantifying enzymes, metabolites, electrolytes, lipids, and proteins in blood to evaluate organ function and metabolic status. This technical article systematically explains the analytical principles, sample requirements, core testing panels, detection methods, clinical applications, and frequently asked questions related to clinical blood biochemistry testing.
Technical Overview
Clinical blood biochemical indicator analysis refers to the quantitative measurement of chemical constituents in blood, including enzymes, substrates, metabolites, electrolytes, lipids, and proteins, using automated biochemistry analyzers and related platforms. These measurements reflect the functional status of major organs such as the liver, kidneys, heart, and pancreas, as well as systemic metabolic processes including glucose homeostasis and lipid metabolism.
The analytical workflow consists of three phases: the pre-analytical phase (patient preparation, specimen collection, transport, and processing), the analytical phase (reaction, detection, and quantification on the analyzer), and the post-analytical phase (result validation, quality control review, and clinical interpretation). Modern automated chemistry analyzers employ photometric, electrochemical, and immunoassay detection technologies, with throughput ranging from 400 to over 10,000 tests per hour on high-speed platforms.
Because biochemical results are influenced by pre-analytical variables, laboratories must control factors such as fasting status, specimen type, hemolysis, lipemia, icterus, anticoagulant interference, and time-to-centrifugation. All results are reported against method-specific reference intervals, and laboratories participate in internal quality control programs and external proficiency testing to ensure accuracy, precision, and comparability.
Testing Samples
Serum
Serum is the most common specimen type for clinical biochemistry. Blood is collected into plain tubes or serum separator tubes (SST) containing a clot activator and separator gel, allowed to clot for 20 to 30 minutes, and then centrifuged to separate the serum from the cellular fraction. Serum is suitable for nearly all routine chemistry analytes, including liver enzymes, kidney function markers, lipids, and proteins. Separator gel provides a stable physical barrier that preserves analyte integrity for up to 24 to 72 hours under refrigerated storage.
Plasma
Plasma is obtained by centrifuging blood collected in anticoagulant tubes, typically lithium heparin for general chemistry or EDTA for specific assays such as glycated hemoglobin. Plasma avoids the clotting step and provides faster turnaround, but reference intervals may differ slightly from serum values due to the presence of fibrinogen and anticoagulant dilution effects. Certain anticoagulants interfere with specific analytes; for example, EDTA chelates calcium and magnesium and must not be used for electrolyte or mineral testing.
Whole Blood
Whole blood is used primarily for point-of-care testing, blood gas analysis (pH, partial pressure of oxygen and carbon dioxide, bicarbonate), and rapid glucose measurement. Heparinized arterial or capillary specimens are analyzed immediately without centrifugation. Glycated hemoglobin (HbA1c) is also measured on whole blood collected into EDTA tubes, since the analyte is bound within erythrocytes.
Pre-Analytical Considerations
- Fasting: 8 to 12 hours of fasting is recommended for glucose and lipid panels; water intake is permitted.
- Timing: Cortisol and iron exhibit diurnal variation; collection time should be recorded.
- Hemolysis: Rupture of erythrocytes releases potassium, LDH, and AST, causing falsely elevated results.
- Lipemia and icterus: Elevated triglycerides or bilirubin interfere with photometric reactions and may require ultracentrifugation or blank correction.
- Tube order: Serum tubes should be drawn before anticoagulant tubes to avoid cross-contamination.
- Stability: Most serum analytes are stable for 24 hours at 2 to 8 degrees Celsius; prolonged room-temperature storage degrades enzymes and glucose.
Testing Items
Clinical blood biochemistry is organized into functional panels. Representative reference intervals are listed below; laboratories must establish or verify assay-specific intervals for their own population and methods.
Liver Function Panel
- Alanine aminotransferase (ALT): 7 to 40 U/L; a specific marker of hepatocellular injury.
- Aspartate aminotransferase (AST): 13 to 35 U/L; elevated in hepatocellular damage, myocardial injury, and muscle disease.
- Alkaline phosphatase (ALP): 45 to 125 U/L; reflects cholestatic disease and bone turnover.
- Gamma-glutamyl transferase (GGT): 10 to 60 U/L for males, 7 to 45 U/L for females; sensitive to cholestasis and alcohol intake.
- Total bilirubin: 3.4 to 20.5 micromol per liter; direct (conjugated) fraction differentiates cholestasis from hemolysis.
- Total protein: 65 to 85 g per liter; albumin 35 to 52 g per liter; reflects hepatic synthetic function and nutritional status.
Kidney Function Panel
- Serum creatinine: 62 to 106 micromol per liter for males, 44 to 80 micromol per liter for females; used with age, sex, and race-free equations to estimate glomerular filtration rate (eGFR).
- Blood urea nitrogen (BUN): 2.5 to 7.1 mmol per liter; influenced by renal function, hydration, and protein intake.
- Uric acid: 208 to 428 micromol per liter for males, 155 to 357 micromol per liter for females; relevant to gout and metabolic syndrome.
- Cystatin C: 0.6 to 1.0 mg per liter; a less muscle-mass-dependent marker of glomerular filtration.
Blood Glucose and Diabetes Markers
- Fasting plasma glucose: 3.9 to 6.1 mmol per liter; values of 7.0 mmol per liter or above on two occasions support a diagnosis of diabetes.
- Glycated hemoglobin (HbA1c): 4 to 6 percent; reflects average glycemia over the preceding 8 to 12 weeks; 6.5 percent or above supports diabetes diagnosis.
- Oral glucose tolerance test (OGTT): 2-hour post-load glucose below 7.8 mmol per liter is normal; 11.1 mmol per liter or above indicates diabetes.
- Fructosamine: reflects glycemic control over 2 to 3 weeks; useful when HbA1c is unreliable due to hemoglobinopathies.
Lipid Profile
- Total cholesterol: below 5.2 mmol per liter is desirable.
- Triglycerides: below 1.7 mmol per liter is desirable; above 5.6 mmol per liter indicates high risk of pancreatitis.
- High-density lipoprotein cholesterol (HDL-C): above 1.0 mmol per liter is considered protective.
- Low-density lipoprotein cholesterol (LDL-C): below 3.4 mmol per liter is desirable for the general population; below 1.8 mmol per liter for very high-risk patients.
- Apolipoprotein A1, apolipoprotein B, and lipoprotein(a): supplementary markers for refined cardiovascular risk assessment.
Electrolytes and Minerals
- Sodium: 135 to 145 mmol per liter; critical for osmotic balance and neurologic function.
- Potassium: 3.5 to 5.5 mmol per liter; values outside this range carry a risk of cardiac arrhythmia.
- Chloride: 96 to 106 mmol per liter; interpreted with sodium and bicarbonate in acid-base evaluation.
- Total calcium: 2.10 to 2.55 mmol per liter; ionized calcium is preferred in critical care.
- Phosphate: 0.97 to 1.61 mmol per liter; regulated with calcium and vitamin D metabolism.
- Magnesium: 0.75 to 1.02 mmol per liter; deficiency affects neuromuscular and cardiac function.
Cardiac and Pancreatic Markers
- Creatine kinase (CK) and CK-MB: 38 to 174 U/L for CK in males; elevated in myocardial and skeletal muscle injury.
- Cardiac troponin I or T: assay-specific 99th percentile cutoffs; the definitive marker for myocardial infarction.
- BNP or NT-proBNP: elevated in heart failure and used for diagnosis and prognosis.
- Homocysteine: elevated levels are associated with increased cardiovascular risk.
- Alpha-amylase: 28 to 100 U/L; lipase: 13 to 60 U/L; both support the diagnosis of acute pancreatitis, with lipase being more specific.
Inflammation and Iron Metabolism Markers
- C-reactive protein (CRP): below 10 mg per liter; high-sensitivity CRP below 1 mg per liter indicates low cardiovascular risk.
- Serum iron, total iron-binding capacity, transferrin saturation, and ferritin: used to differentiate iron deficiency anemia from anemia of chronic disease.
- Prealbumin and transferrin: short half-life nutritional markers used in nutritional monitoring.
Testing Methods
Photometric and Spectrophotometric Methods
The majority of chemistry analytes are measured by UV-visible spectrophotometry using either endpoint or kinetic (rate) reactions. In endpoint assays, absorbance is measured after the reaction reaches completion; in kinetic assays, the change in absorbance per unit time is proportional to enzyme activity or substrate concentration. Examples include the International Federation of Clinical Chemistry (IFCC)-recommended methods for ALT, AST, ALP, and creatinine, and the hexokinase or glucose oxidase methods for glucose.
Ion-Selective Electrode (ISE) Technology
Electrolytes such as sodium, potassium, chloride, and ionized calcium are measured by potentiometry using ion-selective electrodes. Indirect ISE measures a diluted sample and is standard on mainframe analyzers, while direct ISE measures undiluted whole blood and is used in blood gas instruments. Lithium heparin plasma or serum is acceptable, whereas hemolyzed specimens must be rejected for potassium due to intracellular potassium release.
Immunoturbidimetric and Immunoassay Methods
Specific proteins such as CRP, apolipoproteins, immunoglobulins, transferrin, and lipoprotein(a) are quantified by immunoturbidimetry or latex-enhanced immunoturbidimetry on chemistry analyzers. High-sensitivity markers such as troponin and NT-proBNP are measured by chemiluminescent immunoassay on dedicated immunoanalyzer platforms, providing sub-picogram detection limits required for early myocardial infarction diagnosis.
Chromatographic and Electrophoretic Techniques
HbA1c is measured by ion-exchange high-performance liquid chromatography (HPLC), which is the reference method, or by enzymatic and immunoassay approaches certified by standardization programs such as NGSP. Serum protein electrophoresis separates albumin and globulin fractions to detect monoclonal bands, and lipoprotein electrophoresis characterizes dyslipidemia phenotypes.
Quality Assurance and Method Validation
- Calibration: Analyzers are calibrated with traceable calibrators, and calibration verification is performed at defined intervals.
- Internal quality control: Two-level control materials are run daily and evaluated with Westgard multirules before patient results are released.
- External proficiency testing: Participation in inter-laboratory schemes verifies accuracy and comparability.
- Method validation: New assays are verified for precision, accuracy, linearity, analytical sensitivity, and reference interval suitability.
- Delta checks and autoverification: Software rules detect improbable result changes and streamline result release.
Applications
Disease Diagnosis and Differential Diagnosis
Biochemical panels form the diagnostic basis for hepatitis and cirrhosis (liver panel), acute and chronic kidney disease (kidney panel), diabetes mellitus (glucose and HbA1c), dyslipidemia (lipid profile), acute coronary syndrome (troponin), and acute pancreatitis (amylase and lipase). Pattern interpretation, such as the ratio of AST to ALT or the combination of elevated bilirubin and ALP, guides differential diagnosis of hepatocellular versus cholestatic disease.
Health Screening and Preventive Medicine
Annual health examinations routinely include comprehensive metabolic and lipid panels to detect asymptomatic abnormalities such as hyperglycemia, hyperlipidemia, hyperuricemia, and mild renal impairment, enabling early lifestyle intervention and pharmacotherapy before complications develop.
Treatment Monitoring and Prognosis
Serial monitoring tracks disease progression and therapy response: HbA1c every 3 to 6 months for glycemic control, LDL-C for statin titration, creatinine and eGFR for nephrotoxic drug management, and liver enzymes for patients receiving hepatotoxic medications such as antituberculosis agents, methotrexate, or statins. Troponin trends and NT-proBNP levels provide prognostic information in cardiovascular disease.
Critical Care, Perioperative, and Special Populations
In emergency and intensive care settings, rapid electrolyte, glucose, blood gas, and cardiac marker results support immediate therapeutic decisions such as correcting hyperkalemia or initiating reperfusion therapy. Preoperative biochemistry screens assess anesthetic and surgical risk. Pediatric, geriatric, and pregnant populations require age- and physiology-specific reference intervals for correct interpretation.
FAQ
Q: Is fasting required before a blood biochemistry test?
A: An 8 to 12 hour fast is required for accurate glucose and lipid results. Water should be taken normally, and alcohol and heavy exercise should be avoided for 24 hours before collection. Other panels, such as electrolytes, generally do not require fasting, but laboratory instructions should always be followed.
Q: What is the difference between serum and plasma samples?
A: Serum is obtained after blood clots and lacks fibrinogen, whereas plasma is separated from anticoagulated blood and retains clotting factors. Most reference intervals were established on serum, and plasma values may differ slightly; laboratories report results against the appropriate matrix-specific intervals.
Q: Why do results sometimes need to be repeated?
A: Hemolysis, lipemia, icterus, delayed processing, or results failing delta checks can invalidate a specimen. Clinically significant abnormalities are also frequently repeated to exclude pre-analytical error before a diagnosis is made.
Q: Can reference intervals differ between laboratories?
A: Yes. Intervals depend on the analytical method, instrument, population, and statistical approach used. Each laboratory defines its own verified reference intervals, and results should always be interpreted against the intervals printed on the specific report.
Q: How long does it take to obtain results?
A: Routine biochemistry panels on automated analyzers are typically completed within 2 to 4 hours of specimen receipt. Emergency markers such as potassium, glucose, and troponin are reported within 60 minutes under critical value protocols.
Q: How frequently should blood biochemistry testing be performed?
A: Healthy adults are generally screened annually. Patients with diabetes, chronic kidney disease, dyslipidemia, or those on medications affecting the liver or kidneys require individualized monitoring schedules, commonly every 3 to 6 months, as determined by the treating physician.